Position in LLY
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$2,577,575
+$757,351 QoQ
Shares Held
2,149
+8.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#2,272
of 4,621 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MARCO INVESTMENT MANAGEMENT LLC holds $82,947,226 across 10 Drug Manufacturers - General names. LLY ranks #6 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
139,569 | $35,121,143 | |
| 2 | AMGN |
Amgen Inc
|
43,180 | $15,636,341 | |
| 3 | MRK |
Merck & Co., Inc.
|
95,255 | $12,240,267 | |
| 4 | JNJ |
Johnson & Johnson
|
28,817 | $7,318,653 | |
| 5 | PFE |
Pfizer Inc
|
134,025 | $3,227,322 | |
| 6 | LLY |
ELI LILLY & Co
This page
|
2,149 | $2,577,575 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
19,101 | $2,413,220 | |
| 8 | NVS |
Novartis AG
|
13,875 | $2,174,490 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,577,575 | 2,149 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $1,820,224 | 1,979 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $2,092,402 | 1,947 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $1,519,896 | 1,992 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $1,566,855 | 2,010 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $1,690,637 | 2,047 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $1,512,348 | 1,959 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $1,813,519 | 2,047 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,913,067 | 2,113 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $1,611,155 | 2,071 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,299,911 | 2,230 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $1,210,153 | 2,253 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $1,033,162 | 2,203 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $752,433 | 2,191 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $801,555 | 2,191 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $821,632 | 2,541 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $726,599 | 2,241 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $613,118 | 2,141 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $605,474 | 2,192 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $485,205 | 2,100 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $481,992 | 2,100 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $392,322 | 2,100 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $354,564 | 2,100 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $310,842 | 2,100 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $344,778 | 2,100 | Shares | Sole | 2020-07-21 | |
| 2020-03-31 | $291,312 | 2,100 | Shares | Sole | 2020-04-17 | |
| No filing history on record for this holder in this stock. | ||||||